Detalhe da pesquisa
1.
Perioperative Nivolumab in Resectable Lung Cancer.
N Engl J Med
; 390(19): 1756-1769, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38749033
2.
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Nature
; 596(7870): 126-132, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34290408
3.
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(18): 1672-1684, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870974
4.
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 387(17): 1557-1568, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36094839
5.
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
N Engl J Med
; 386(21): 1973-1985, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403841
6.
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade.
J Transl Med
; 22(1): 241, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443917
7.
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
Lancet Oncol
; 24(11): 1196-1205, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875144
8.
Whole-Slide Imaging, Mutual Information Registration for Multiplex Immunohistochemistry and Immunofluorescence.
Lab Invest
; 103(8): 100175, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196983
9.
Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists.
Mod Pathol
; 36(7): 100197, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105494
10.
Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system.
CA Cancer J Clin
; 66(5): 408-36, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27270763
11.
Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer.
Future Oncol
; 19(8): 549-557, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815433
12.
Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer.
Prostate
; 82(6): 706-722, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35188986
13.
Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021.
J Transl Med
; 20(1): 257, 2022 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672823
14.
Immune cell subsets in interface cutaneous immune-related adverse events associated with anti-PD-1 therapy resemble acute graft versus host disease more than lichen planus.
J Cutan Pathol
; 49(8): 701-708, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445765
15.
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.
Nature
; 598(7881): E1, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34608287
16.
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
N Engl J Med
; 378(21): 1976-1986, 2018 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29658848
17.
Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
Cancer Immunol Immunother
; 70(5): 1227-1237, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33125511
18.
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy).
J Transl Med
; 19(1): 238, 2021 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34078406
19.
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).
J Transl Med
; 18(1): 346, 2020 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32894202
20.
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
Lancet Oncol
; 20(7): e378-e389, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31267972